<!doctype html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Mohcine Madkour, Big Data Architectures and more">


        <title>Diagnostic model for predicting Cardiovascular Disease Risk using Genomics data // Mohcine Madkour // Big Data Architectures and more</title>


    <link rel="stylesheet" href="//cdnjs.cloudflare.com/ajax/libs/pure/0.3.0/pure-min.css">
    <link rel="stylesheet" href="//cdnjs.cloudflare.com/ajax/libs/font-awesome/4.1.0/css/font-awesome.min.css">
    <link rel="stylesheet" href="../../../../theme/css/pure.css">
    <link rel="stylesheet" href="../../../../theme/css/pygments.css">

    <script src="//cdnjs.cloudflare.com/ajax/libs/jquery/2.0.3/jquery.min.js"></script>
    <script src="//cdnjs.cloudflare.com/ajax/libs/fitvids/1.0.1/jquery.fitvids.min.js"></script>
    <script>
        $(document).ready(function(){
            $(".content").fitVids();
        });
    </script>
</head>

<body>
<div class="pure-g-r" id="layout">
    <div class="sidebar sidebar-article pure-u">
        <header class="header-article">
            <hgroup>
                <a href="../../../../author/mohcine-madkour.html" title="See posts by Mohcine Madkour">
                        <img class="avatar" alt="Mohcine Madkour" src="http://www.gravatar.com/avatar/ae08847efc1a85b710f326eb8ee2e907">
                </a>
                <h2 class="article-info">Mohcine Madkour</h2>
                <small class="about-author"></small>
                <h5>Published</h5>
                <p>Sun 21 July 2019</p>
                <a href="/">&larr;Home</a>
            </hgroup>
        </header>
    </div>
    <div class="pure-u">
        <div class="content">
            <section class="post">
                <header class="post-header">
                    <h1>Diagnostic model for predicting Cardiovascular Disease Risk using Genomics data</h1>
                        <p class="post-meta">
                            // under                                 <a class="post-category" href="../../../../tag/machine-learning/">Machine Learning</a>
                                <a class="post-category" href="../../../../tag/prevention-of-cardiovascular-disease/">Prevention of cardiovascular disease</a>
                                <a class="post-category" href="../../../../tag/risk-prediction/">Risk prediction</a>
                        </p>
                </header>
            </section>
            <p>Prevention of cardiovascular disease (CVD) requires timely identification of people who are at increased risk in order to target effective dietary, lifestyle, or pharmacotherapeutic intervention—or a combination of the 3. Risk factors for CVD are well understood, but the relative impact of each factor on an individual’s overall risk is difficult to accurately quantify, making a validated CVD risk calculator an important clinical tool. The first widely used cardiovascular risk prediction equation was the Framingham Risk Score (FRS), developed from the country's first longitudinal cardiovascular cohort study. Eventual adoption of the FRS firmly established absolute risk assessment as an integral part of primary prevention, operationalizing the widely accepted paradigm that more intensive prevention efforts, specifically drug therapy, should be directed to those at higher risk.</p>
<p>Although the original Framingham cohort has been expanded multiple times since its inception, clinicians and researchers continue to express concern that the predominantly white, middle-class Framingham, Massachusetts, population might not be representative of the United States in general—which would limit the accuracy of the FRS predictive tool when it is applied to a more diverse population. Furthermore, cholesterol-lowering medications were not available when the FRS was first developed. The FRS, therefore, might not accurately estimate risk in more modern populations, in whom aggressive modification of CVD risk factors has resulted in a lower overall rate of atherosclerotic CVD than when the FRS was developed.</p>
<p>Despite numerous available CVD risk calculators, one best tool has yet to emerge. This state of affairs has limited the ability of front-line providers who are tasked with primary prevention of CVD—including family physicians (FPs)—to provide the best evidence-based recommendations to patients.</p>
<p><img alt="/images/media/image1.jpeg" src="http://annals.org/data/Journals/AIM/931895/2ff1_Box_A_Schematic_representation_of_diagnostic_and_prognostic_prediction_modeling_studies.jpeg"></p>
<p>Credit: TRIPOD group (Collins et al), Annals, 2015.
http://annals.org/aim/article/2088549/transparent-reporting-multivariable-prediction-model-individual-prognosis-diagnosis-tripod-tripod</p>
<table>
<thead>
<tr>
<th><strong>Model</strong></th>
<th><strong>1 Framingham (D’Agostino)</strong></th>
<th><strong>2 ASCVD risk (Muntner)</strong></th>
<th><strong>3 Jackson Heart Study (Fox)</strong></th>
<th><strong>4 Mesa</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>WHY</td>
<td>Heart attack and stroke risk could be identified</td>
<td>Variation by race and geography</td>
<td>Models don’t capture race or new variables</td>
<td>Increase ethnicity mix in scoring; add coronary artery calcium (CAC) + other data</td>
</tr>
<tr>
<td>HOW: General Model development Model validation</td>
<td>Use Heart Study to predict outcomes Cox proportional-hazards regression Limited; no training set</td>
<td>Used REGARDS study Stratified logistic regression Separate data set (the ref)</td>
<td>Jackson Study all black Cox proportional-hazards regression Separate sets</td>
<td>Cohort study from 2000-present Cox proportional-hazards regression Unusual – repeat lots of other risk scores, <strong>add</strong> in CAC</td>
</tr>
<tr>
<td>WHAT they found: Participants</td>
<td>8491 in Framingham study</td>
<td>18500 Medicare eligible patients in study</td>
<td>2200 (Training) + 2300 (Validation)</td>
<td>6184 persons – Caucasian, Chinese, African American, Hispanic</td>
</tr>
<tr>
<td>Model specification</td>
<td>Gender stratified, uses Age, Total Cholesterol, HDL, SBP, Diabetes, Smoking, Treatment for HTN</td>
<td>Separates Race, Gender, treatment for HTN, uses Age, Total Cholesterol, HDL, SBP, Diabetes, Smoking</td>
<td>6 models; as left but no stratification + GFR; added BNP, CIMT, ABI, Echo of heart failure, A1c</td>
<td>Add CAC, CRP to standard scores</td>
</tr>
<tr>
<td>Model performance</td>
<td>C-stat: men .749, women .785 Hosmer-Lemeshow p=.08-.41</td>
<td>C-Stat: 0.71 (.66-.75) H-L p=.14-.56</td>
<td>C-stat: 0.77-0.83; Validation: .70-.77 ; no sig improvement</td>
<td>C-stat not available; increase risk in intermediate group</td>
</tr>
<tr>
<td>WHAT it means</td>
<td>Add CAC, CRP if intermediate risk</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Credit to:</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<p>Framingham RS,
<a href="http://circ.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=18212285">http://circ.ahajournals.org/cgi/pmidlookup?view=long&amp;pmid=18212285</a></p>
<p>ASCVD, https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24682252/</p>
<p>JHS, <a href="http://jamanetwork.com/journals/jamacardiology/fullarticle/2492417">http://jamanetwork.com/journals/jamacardiology/fullarticle/2492417</a></p>
<p>Mesa, <a href="https://www.ncbi.nlm.nih.gov/pubmed/25686167">https://www.ncbi.nlm.nih.gov/pubmed/25686167</a>,
<a href="http://www.sciencedirect.com/science/article/pii/S0021915006004047">http://www.sciencedirect.com/science/article/pii/S0021915006004047</a></p>
<h1>The ASCVD risk scores!</h1>
<table>
<thead>
<tr>
<th></th>
<th>Equations parameters*</th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td>S0(t) at 5 years†</td>
<td>S0(t) at 10 years</td>
<td>Mean score</td>
<td>Individual score</td>
</tr>
<tr>
<td><strong>Participants not taking antihypertensive medications</strong></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Black women</td>
<td>0.98194</td>
<td>0.9533</td>
<td>86.61</td>
<td>= 17.114 × ln(age) + 0.94 × ln(TC) - 18.92 × ln(HDL-C) + 4.475 × ln(age) × ln(HDL-C) + 27.82 × ln(SBP) - 6.087 × ln(age) × ln(SBP) (+ 0.691 if current smoker) (+ 0.874 if diabetes)</td>
</tr>
<tr>
<td>White women</td>
<td>0.98898</td>
<td>0.9665</td>
<td>-29.18</td>
<td>= - 29.799 × ln(age) + 4.884 × ln(age)2 + 13.54 × ln(TC) - 3.114 × ln(age) × ln(TC) -13.578 × ln(HDL-C) + 3.149 × ln(age) × ln(HDL-C) + 1.957 × ln(SBP) (+ 7.574 - 1.665 × ln(age) if current smoker) (+ 0.661 if diabetes)</td>
</tr>
<tr>
<td>Black men</td>
<td>0.95726</td>
<td>0.8954</td>
<td>19.54</td>
<td>= 2.469 × ln(age) + 0.302 × ln(TC) - 0.307 × ln(HDL-C) + 1.809 × ln(SBP) (+ 0.549 if current smoker) (+ 0.645 if diabetes)</td>
</tr>
<tr>
<td>White men</td>
<td>0.96254</td>
<td>0.9144</td>
<td>61.18</td>
<td>= 12.344 × ln(age) + 11.853 × ln(TC) - 2.664 × ln(age) × ln(TC) - 7.99 × ln(HDL-C) + 1.769 × ln(age) × ln(HDL-C) + 1.764 × ln(SBP) (+ 7.837 - 1.795 × ln(age) if current smoker) (+ 0.658 if diabetes)</td>
</tr>
<tr>
<td><strong>Participants taking antihypertensive medications</strong></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Black women</td>
<td>0.98194</td>
<td>0.9533</td>
<td>86.61</td>
<td>= 17.114 × ln(age) + 0.94 × ln(TC) - 18.92 × ln(HDL-C) + 4.475 × ln(age) × ln(HDL-C) + 29.291 × ln(SBP) - 6.432 × ln(age) × ln(SBP) (+ 0.691 if current smoker) (+ 0.874 if diabetes)</td>
</tr>
<tr>
<td>White women</td>
<td>0.98898</td>
<td>0.9665</td>
<td>-29.18</td>
<td>= - 29.799 × ln(age) + 4.884 × ln(age)2 + 13.54 × ln(TC) - 3.114 × ln(age) × ln(TC) -13.578 × ln(HDL-C) + 3.149 × ln(age) × ln(HDL-C) + 2.019 × ln(SBP) (+ 7.574 - 1.665 × ln(age) if current smoker) (+ 0.661 if diabetes)</td>
</tr>
<tr>
<td>Black men</td>
<td>0.95726</td>
<td>0.8954</td>
<td>19.54</td>
<td>= 2.469 × ln(age) + 0.302 × ln(TC) - 0.307 × ln(HDL-C) + 1.916 × ln(SBP) (+ 0.549 if current smoker) (+ 0.645 if diabetes)</td>
</tr>
<tr>
<td>White men</td>
<td>0.96254</td>
<td>0.9144</td>
<td>61.18</td>
<td>= 12.344 × ln(age) + 11.853 × ln(TC) - 2.664 × ln(age) × ln(TC) - 7.99 × ln(HDL-C) + 1.769 × ln(age) × ln(HDL-C) + 1.797 × ln(SBP) (+ 7.837 - 1.795 × ln(age) if current smoker) (+ 0.658 if diabetes)</td>
</tr>
<tr>
<td>ASCVD: atherosclerotic cardiovascular disease; HDL-C: high-density lipoprotein cholesterol; REGARDS: REasons for Geographic And Racial Differences in Stroke; SBP: systolic blood pressure; TC: total cholesterol. * Final risk estimation is calculated as:</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<p>$$
\mathbf{\text{Predicted}}\ \mathbf{\text{ASCVD}}\ \mathbf{\text{risk}} = \mathbf{1} - \mathbf{S}_{\mathbf{0}}\left( \mathbf{t} \right)^{\mathbf{e}^{(\mathbf{\text{Individual}}\ \mathbf{\text{score}} - \mathbf{\text{Mean}}\ \mathbf{\text{score}})}}\ 
$$
† Obtained from the ACC/AHA Guideline on the Assessment of Cardiovascular Risk
working group (S. Coady, Personal Communication).
what do you expect? What factors increase risk?
===============================================
| <strong>Case examples</strong>                                                                                                                                                         | <strong>Framingham1</strong>         | <strong>ASCVD2</strong>             | <strong>Mesa3</strong>             |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------|------------------------|-----------------------|
| Smythe 68 year old white male with Chol of 250, HDL of 40, LDL 120, SBP 123, no other illnesses - what if black male? - what if white female? - what if smoker?           | 16.8% 16.8%? 5.2% 18.3% | 18.7% 11.7% 8.5% 23.6% | 10.1% 8.3% 4.9% 15.7% |
| Chavez 45 year old Hispanic female with Chol of 200, HDL 40, LDL 101 SBP 150 Diabetes and smoker. Not treated for HTN. - what if CAC is 350 Agatston units? - what if 39? | 4.7% 4.7%? 3.6%         | 11.6% 11.6%? N/A       | 3.7% 14.2% N/A        |
| Lee 55 year old Asian male with Chol of 130 LDL 50 HDL 50 SBP 170 treated for HTN (not well) no diabetes and never smoked                                                 | 6.1%                    | 6.6%                   | 3.4%                  |
Clinical Study Reporting
========================
<img alt="http://annals.org/data/Journals/AIM/931895/9tt1_Table_Checklist_of_Items_to_Include_When_Reporting_a_Study_Developing_or_Validating_a_Multi.jpeg" src="/images/media/807d0e4173bbfaec1129c7ade248ce5c.jpg">
<img alt="http://annals.org/data/Journals/AIM/931895/9tt1_Table_Checklist_of_Items_to_Include_When_Reporting_a_Study_Developing_or_Validating_a_Multi.jpeg" src="/images/media/807d0e4173bbfaec1129c7ade248ce5c.jpg">
<img alt="http://annals.org/data/Journals/AIM/931895/9tt1_Table_Checklist_of_Items_to_Include_When_Reporting_a_Study_Developing_or_Validating_a_Multi.jpeg" src="/images/media/807d0e4173bbfaec1129c7ade248ce5c.jpg">
<img alt="http://annals.org/data/Journals/AIM/931895/9tt1_Table_Checklist_of_Items_to_Include_When_Reporting_a_Study_Developing_or_Validating_a_Multi.jpeg" src="/images/media/807d0e4173bbfaec1129c7ade248ce5c.jpg">
Genetics and Cardiovascular Risk
================================
<img alt="" src="/images/media/3548125eb8e7822ddd8ddce0b89dcecf.jpg">
Credit: <a href="https://cnx.org/contents/8v2Xzdco@3/The-Structure-of-DNA">https://cnx.org/contents/8v2Xzdco@3/The-Structure-of-DNA</a>
What is a SNP?</p>
<hr>
<p>A SNP (Single Nucelotide Polymorphism) is a single base-pair location in the
genome where we observe variation across a population.
We need two pieces of information to locate a snp: the chromosome it’s on, and
the linear position on the chromosome.
<img alt="C:\Users\qq834\AppData\Local\Microsoft\Windows\INetCache\Content.Word\download.png" src="/images/media/9a49a7f3c1c89806ba98187b9f5cee04.png">
Snp Image by David Hall / CC Licensed
Parents and genetics</p>
<hr>
<p>Because we have two chromosomes (one from each parent), we will have two copies
(values) at any SNP. Each of these copies is called an <em>allele</em>.
For example, if my dad gave me a copy (allele) with an A, and my mom gave me a
copy (allele) with a G, my genotype at that SNP location would be AG.
SNP Frequencies</p>
<hr>
<p>We classify the different genotypes based on how frequently they are observed in
the population.
Nomenclature: if a genotype is observed most of the time, we term that genotype
the <em>wild type</em> (WT). The other genotype is called the <em>variant</em>, and by
definition occurs less than the wild type.
Based on population studies, we can see that genotype frequencies vary by racial
population. Is this reflected in our genotype data?
<img alt="C:\Users\qq834\AppData\Local\Microsoft\Windows\INetCache\Content.Word\download (2).png" src="/images/media/6e7319ff2bf0ba77955ca39a973fefe4.png">
Snppedia Snapshot
SNPs are associated with disease</p>
<hr>
<p>A number of SNPs have been associated with CVD. Having a variant can increase
your overall risk of having CVD.
A number of these SNPs are associated with genes involving lipid synthesis.
<img alt="" src="/images/media/49470225a6341462340941f1f94cb6ba.png">
Credit:
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507276/pdf/nihms-703604.pdf">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507276/pdf/nihms-703604.pdf</a>
<a href="https://github.com/laderast/cvdNight1">EDA code</a>
<a href="https://github.com/laderast/cvdNight2">Genetics Model</a></p>
            <div class="hr"></div>
            <a href="#" class="go-top">Go Top</a>
<div class="comments">
    <div id="disqus_thread"></div>
    <script type="text/javascript">
        /* * * CONFIGURATION VARIABLES: EDIT BEFORE PASTING INTO YOUR WEBPAGE * * */
        var disqus_shortname = "leafyleap-2"; // required: replace example with your forum shortname

        /* * * DON'T EDIT BELOW THIS LINE * * */
        (function() {
            var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true;
            dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js';
            (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq);
        })();
    </script>
    <noscript>Please enable JavaScript to view the <a href="http://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
    <a href="http://disqus.com" class="dsq-brlink">comments powered by <span class="logo-disqus">Disqus</span></a>
</div><footer class="footer">
    <p>&copy; Mohcine Madkour &ndash;
        Built with <a href="https://github.com/PurePelicanTheme/pure">Pure Theme</a>
        for <a href="http://blog.getpelican.com/">Pelican</a>
    </p>
</footer>        </div>
    </div>
</div>
    <script>
        var $top = $('.go-top');

        // Show or hide the sticky footer button
        $(window).scroll(function() {
            if ($(this).scrollTop() > 200) {
                $top.fadeIn(200);
            } else {
                $top.fadeOut(200);
            }
        });

        // Animate the scroll to top
        $top.click(function(event) {
            event.preventDefault();
            $('html, body').animate({scrollTop: 0}, 300);
        })

        // Makes sure that the href="#" attached to the <a> elements
        // don't scroll you back up the page.
        $('body').on('click', 'a[href="#"]', function(event) {
            event.preventDefault();
        });
    </script>
</body>
</html>